Ink-jet as a manufacturing method for drug delivery applications

Proceedings of the ASME International Manufacturing Science and Engineering Conference, MSEC2008

Volumn 2, Issue , 2009, Pages 525-534

  Antohe, Bogdan V ^a   Wallace, David B ^a  

^a MICROFAB TECHNOLOGIES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE AGENTS; ACTIVE COMPONENTS; DATA-DRIVEN; DELIVERY VEHICLE; DRUG DELIVERY APPLICATIONS; DRUG LOADED MICROSPHERE; DRUG-ELUTING STENTS; INK JET TECHNOLOGY; INK-JET; INK-JET METHODS; MANUFACTURING APPLICATIONS; MANUFACTURING LINES; MANUFACTURING METHODS; NERVE CONDUITS; NERVE GROWTH FACTOR; NON-CONTACT TECHNIQUES; NON-PLANAR SURFACES; PICOLITER VOLUMES; TARGET SITES; TRANSDERMAL DELIVERY;

BIOLOGICAL MATERIALS; DRUG DELIVERY; FLEXIBLE MANUFACTURING SYSTEMS; INK;

DRUG DOSAGE;

EID: 77951589542     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1115/MSEC_ICMP2008-72248     Document Type: Conference Paper

References (60)

1. P.H. Chong and J.W.M. Cheng, Early Experiences and Clinical Implications of Drug-Eluting Stents: Part 1, The Annals of Pharmacotherapy 38 (2004) 661-669.
2. P.W. Serruys et al., The Effect of Variable Dose and Release Kinetics on Neointimal Hyperplasia Using a Novel Paclitaxel-Eluting Stent Platform, Journal of the American College of Cardiology 46 (2005) 253-260.
3. M. Xie, L. Zhou, T. Hu and M. Yao, Intratumoral delivery of paclitaxel-loaded poly(lactic-co-glycolic acid) microspheres for Hep-2 laryngeal squamous cell carcinoma xenografts, Anticancer Drugs 18 (2007) 459-466
4. J.H. Jang and L.D. Shea, Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression, J. Control Release 112 (2006) 120-128.
5. A. Piotrowicza and M.S. Shoichet, Nerve guidance channels as drug delivery vehicles, Biomaterials 27 (2006) 2018-2027.
6. T. Welch, R.C. Eberhart and C.J. Chuong, Characterizing the Expansive Deformation of a Bioresorbable Polymer Fiber Stent, Ann. Biomed Eng. E publication (Feb 9 2008).
7. T. Sharkawi, F. Cornhill, A. Lafont, P. Sabaria and M. Vert, Intravascular bioresorbable polymeric stents: a potential alternative to current drug eluting metal stents, J. Pharm Sci. 96 (2007) 2829-2837.
8. H.J. Chung and T.G. Park, Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering, Advanced Drug Delivery Reviews 59 (2007) 249-262.
9. D.B. Wallace, A Method of Characteristics Model of a Drop-On-Demand Ink-Jet Device Using an Integral Method Drop Formation Model, ASME publication 89-WA/FE-4, December 1989.
10. J.S. Aden, J.H. Bohorquez, D.M. Collins, M.D. Crook, A. Garcia, and U.E. Hess, The Third Generation HP Thermal InkJet Printhead, Hewlett-Packard Journal 45, February 1994.
11. D.B. Bogy and F.E. Talke, Experimental and Theoretical Study of Wave Propagation Phenomena in Drop-On-Demand Ink Jet Devices, IBM Journ. Res. Develop. 29 (1984) 314-321.
12. J.F. Dijksman, Hydrodynamics of Small Tubular Pumps, Journ. Fluid Mech. 139(1984), 173-191.
13. G. Tepe, J. Schmehl, H.P. Wendel, S. Schaffner, S. Heller, M. Gianotti, C.D. Claussen, S.H. Duda, Reduced thrombogenicity of nitinol stents - In vitro evaluation of different surface modifications and coatings, Biomaterials 27 (2006) 643-650.
14. I.A. Khan and V.B. Patravale, The Intra-Vascular Stent as a Site-Specific Local Drug Delivery System, Drug Development and Industrial Pharmacy 1 (2005) 59-78.
15. P.W. Serruys and B.J. Rensing, Handbook of Coronary Stents 4th Edition, Martin Dunitz Ltd, London, 2002.
16. P.W. Serruys and A.H. Gershlink, Handbook of Drug-Eluting Stents, Taylor & Francis, London, 2005.
17. R.D. Winslow, S.K. Sharma and M.C Kim, Restenosis and Drug-eluting stents, The Mount Sinai Journal of Medicine 72 (2005) 81-89.
18. L.Buellesfeld and E. Grube, ABT-578-Eluting Stents. The Promising Successor of Sirolimus-and Paclitaxel-Eluting Stent Concepts? Herz 29 (2004) 167-170.
19. G.X. Wang, X.Y. Deng, C.J. Tang, L.S. Liu, L Xiao, L.H. Xiang, X.J. Quan, A.P. Legrand and R. Guidoin, The Adhesive Properties of Endothelial Cells on Endovascular Stent Coated by Substrates of Poly-L-Lysine and Fibronectin, Artificial Cells Blood Substitutes and Biotechnology 34 (2006) 11-25.
20. P.W. Radke, U. Griesenbach, A. Kivela, T. Vick, D. Judd, F. Munkonge, S. Willis, D.M. Geddes, S. Ylahertuala, and E. ALTON, Vascular Oligonucleotide Transfer Facilitated by a Polymer-Coated Stent, Human Gene Therapy 16 (2005) 734-740.
21. P. Roy-Chaudhury, Endothelial Progenitor Cells, Neointimal Hyperplasia, and Hemodialysis Vascular Access Dysfunction: Novel Therapies for a Recalcitrant Clinical Problem, Circulation 112 (2005) 3-5.
22. D.A. Cooley, Will Drug-Eluting Stents Replace Coronary Artery Bypass Surgery?, Texas Heart Institute Journal 32 (2005) 323-330.
23. J. Pache, A. Dibra, J. Mehilli, J. Dirschinger, A. Schomig and A. Kastrati, Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial, European Heart Journal 26 (2005) 1262-1268.
24. R.G. Laham, Drug Eluting Stents for Everyone and Everything? Catheterization and Cardiovascular Interventions, 66 (2005) 512-551
25. A. Comarow, In Cold Blood, U.S. News, December 11 (2006) 82-84.
26. J. Stommen, Cardio Firms Attract Interested Listeners at Investor Gathering, Cardiovascular Device Update 12 (2006) 1-6.
27. P.J. Tarcha, D. VerLee, H.-W. Hui, J. Setesak, K. Andelin, A. Shows, D. Wallace, D. Radulescu, and B.V. Antohe, Drug Loading of Stents with Ink-Jet Technology, Proceedings Biolnterface 2004, Surfaces in Biomaterials Annual Symposium and Exhibition, October 27-29 2004, Baltimore, MD, USA.
28. D. Verlee, P. Tarcha, K. Cromack, R. Quint, Method of loading beneficial agent to a prosthesis by fluid-jet application, USP 7, 208, 190, April 24, 2007.
29. A. Shekalim and A. Shmulewitz, Stent Coating Device, USP 6,645,547, Nov. 11, 2003.
30. D.S. Hunter, Method and Apparatus for Loading a Beneficial Agent into an Expandable Medical Device, USP Application 20040127976, July 1, 2004.
31. D. Verlee, P. Tarcha, K. Cromack, J. Toner, H-W. Hui, Prosthesis with multiple drugs applied separately by fluid jet application in discrete unmixed droplets, USP Application 20040185081, September 23, 2003.
32. P. Tarcha, D. Verlee, H. Hui, J. Setesak, B. Antohe, D. Radulescu and D. Wallace, The Application of Ink-Jet Technology for the Coating and Loading of Drug-Eluting Stents, Annals of Biomedical Engineering 35 (2007) 1791-1799.
33. J. F. Shanley and T.L. Parker, Implantable medical device with drug filled holes, USP 7, 208, 011, April 24, 2007.
34. http://www.labcoat-ltd.com/content.asp, accessed March 27, 2008.
35. A.H. Shikani and A.J. Domb, Polymer chemotherapy for head and neck cancer, Laryngoscope 110 (2000) 907-917.
36. L. Elomaa, H. Joensuu and J. Kulmala, Squamous cell carcinoma is highly sensitive to Taxol, a possible new radiation sensitizer, Acta Otolaryngol. 115 (1995) 340-344.
37. E.K. Rowinsky and R.C. Donehower, Paclitaxel (Taxol), N. Eng. J. Med. 332 (1995) 1004-1014.
38. H.M. Burt, J.K. Jackson, S.K. Bains, R.T. Liggins, A.M.C. Oktaba, A.L. Arsenault and W.L. Hunter, Controlled delivery of taxol microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid), Cancer Lett. 88 (1995)73-79.
39. S.K. Dordunoo, J.K. Jackson, L.A. Arsenalt, A.M.C. Oktaba, W.L. Hunter and H.M. Burt, Taxol encapsulation in poly(epsilon-caproactone) microspheres, Cancer Chemother. Pharmacol. 36 (1995) 279-282.
40. S.K. Dordunoo, A.M.C. Oktaba, W. Hunte, W. Min, T. Cruz and H.M. Burt, Release of taxol from poly(e-caprolactine) pastes: effect of water soluble additives, J Controlled Rel. 44 (1997) 87-94.
41. M.E. Stearns and M. Wang, Taxol blocks processes essential for prostate tumor cell (PC-3ML) invasion and metastases, Cancer Res. 52 (1992) 3776-3781.
42. N.K. Ibrahim, N. Desai, S. Legha, P. Soon-Shiong, R.L. Theriault, E. Rivera, B. Esmaeli, S.E. Ring, A. Bedikian, G.N. Hortobagyi and J.A. Ellerhorst, Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel, Clin. Cancer. Res. 8 (2002) 1038-1044.
43. D. Radulescu, Method for forming polymer microspheres, U.S. patent 6,998,074, February 14, 2006.
44. G. Lundborg, Alternatives to autologous nerve grafts, Handchir Mikrochir Plast Chir. 36 (2004) 1-7.
45. R. Langer and J.P. Vacanti, Tissue Engineering, Science 260 (1993) 920-926.
46. G. Lundborg and H.A. Hansson, Nerve regeneration through preformed pseudosynovial tubes, J. Hand Surg. 5 (1980) 35-38.
47. S.J. Archibald, C. Krarup, J. Shefner, S.T. Li and M.D. Madison, A collagen-based nerve guide for peripheral nerve repair: An electrophysiological study of nerve regeneration in rodents and nonhuman primates, J. Comp. Neurol. 306 (1991) 685-696.
48. R.D. Fields and M.H. Ellsman, Axons regenerated through silicone tube splices, Exp. Neurol. 92 (1986) 48-60
49. M.F. Meek and J.H. Coert, Cllinical Use of Nerve Conduits in Peripheral Nerve Repair: review of the Literature, J. Reconstr. Microsurg. 18 (2002) 97-109.
50. J.C. Jimenez, D.R. Tyson, S. Dhar, T. Nguyen, Y. Hamai, R.A. Bradshaw, G.R.D. Evans, Human embryonic kidney cells (HEK-293 cells): characterization and dose-response relationship for modulated release of nerve growth factor for nerve regeneration, Plast Reconstr Surg. 113 (2004) 605-610.
51. J. IJkema-Paassen, K. Jansen, A. Gramsbergen and M.F. Meek, Transection of peripheral nerves, bridging strategies and effect evaluation, Biomaterials 25 (2004) 1583-1592.
52. G.R. Evans, Approaches to tissue engineered peripheral nerve, Clin. Plast. Surg. 30 (2003) 559-563.
53. M. Dezawa, Central and peripheral nerve regeneration by transplantation of Schwann cells and transdifferentiated bone marrow stromal cells, Anat. Sci. Int. 77 (2002) 12-25.
54. M.P. McConnell, S. Dhar, T. Nguyen, S. Naran, J.W. Calvert, M.J. Sundine, R.A. Bradshaw and G.R. Evans, Nerve growth factor expression response to induction agent booster dosing in transfected human embryonic kidney cells, Plast. Reconstr. Surg. 115 (2005), 506-514.
55. M.P. McConnell, S. Dhar, S. Naran, T. Nguyen, R.A. Bradshaw and G.R. Evans, In vivo induction and delivery of nerve growth factor using HEK-293 cells, Tissue. Eng., 10 (2004) 1492-1501.
56. D. Radulescu, S. Dhar, C. M. Young, D.W. Taylor, H.-J. Trost, D. J. Hayes, G. R. Evans, Tissue Engineering Scaffolds for Nerve Regeneration Manufactured by Ink-Jet Technology, Materials Science and Technology Conference 2005, September 25-28, 2005, Pittsburgh, PA, USA.
57. A.L. Teo, C. Shearwood, K.C. Nga, J.L. and S. Moochhala, Transdermal microneedles for drug delivery applications, Materials Science and Engineering B 132 (2006) 151-154.
58. H.S. Gill and M.R. Prausnitz, Coated microneedles for transdermal delivery, Journal of Controlled Release 117 (2007) 227-237.
59. H.S. Gill and M.R. Prausnitz, Pocketed microneedles for drug delivery to the skin, J. Phys. Chem. Solids (2007), doi: 10.1016/j.jpcs.2007.10.059.
60. N.-C. Tsai and C.-Y. Sue, Review of MEMS-based drug delivery and dosing systems, Sensors and Actuators A 134 (2007) 555-564.